DK0458861T3 - Middel til reparation og forebyggelse af fibrotiske læsioner - Google Patents

Middel til reparation og forebyggelse af fibrotiske læsioner

Info

Publication number
DK0458861T3
DK0458861T3 DK90903464.7T DK90903464T DK0458861T3 DK 0458861 T3 DK0458861 T3 DK 0458861T3 DK 90903464 T DK90903464 T DK 90903464T DK 0458861 T3 DK0458861 T3 DK 0458861T3
Authority
DK
Denmark
Prior art keywords
prevention
repair
fibrotic lesions
fibrotic
pyridone
Prior art date
Application number
DK90903464.7T
Other languages
Danish (da)
English (en)
Inventor
Solomon B Margolin
Original Assignee
Solomon B Margolin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solomon B Margolin filed Critical Solomon B Margolin
Application granted granted Critical
Publication of DK0458861T3 publication Critical patent/DK0458861T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DK90903464.7T 1989-02-15 1990-01-26 Middel til reparation og forebyggelse af fibrotiske læsioner DK0458861T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1035436A JPH02215719A (ja) 1989-02-15 1989-02-15 線維化病変組織の修復並びに線維化病変の阻止剤

Publications (1)

Publication Number Publication Date
DK0458861T3 true DK0458861T3 (da) 1996-08-12

Family

ID=12441800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90903464.7T DK0458861T3 (da) 1989-02-15 1990-01-26 Middel til reparation og forebyggelse af fibrotiske læsioner

Country Status (9)

Country Link
EP (3) EP0458861B1 (enExample)
JP (1) JPH02215719A (enExample)
AT (1) ATE136215T1 (enExample)
AU (1) AU633541B2 (enExample)
CA (1) CA2010017C (enExample)
DE (2) DE69033863T2 (enExample)
DK (1) DK0458861T3 (enExample)
ES (2) ES2163389T3 (enExample)
WO (1) WO1990009176A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02215719A (ja) * 1989-02-15 1990-08-28 Yamauchi Akitomo 線維化病変組織の修復並びに線維化病変の阻止剤
US5716632A (en) * 1989-11-22 1998-02-10 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
WO1994026249A1 (en) * 1993-05-07 1994-11-24 Margolin Solomon B Compositions and methods for reparation and prevention of fibrotic lesions
DE69632396T2 (de) * 1995-03-03 2005-05-04 Margolin, Solomon B., Dallas Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
US6492395B1 (en) 1998-09-18 2002-12-10 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
JP4542743B2 (ja) 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
TW200501952A (en) * 2003-02-21 2005-01-16 Shionogi & Co Pirfenidone gel formulations
TW200418516A (en) * 2003-02-21 2004-10-01 Shionogi & Co Droplet dispersed ointment
CA2545813C (en) 2003-11-14 2011-01-04 Shanghai Genomics, Inc. The derivatives of pyridone and use thereof
CN1846699A (zh) * 2005-04-13 2006-10-18 中南大学湘雅医院 1－(取代苯基)－5－甲基－2－(1h) 吡啶酮(i)化合物用于制备抗除肾间质纤维化外其他器官纤维化或组织纤维化药物的应用
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
CA2656017C (en) 2006-06-15 2014-02-04 Shanghai Genomics, Inc. Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries
MX2007006347A (es) * 2007-05-29 2009-02-18 Cell Therapy And Technology S Nuevo uso de 5-metil-1-fenil-2-(1h)-piridona para el tratamiento y prevencion de cicatrices hipertroficas, y composicion conteniendo la misma.
ES2400026T3 (es) 2007-06-20 2013-04-05 Auspex Pharmaceuticals, Inc. N-arilpiridinonas sustituidas como inhibidores fibróticos
US20100099719A1 (en) * 2008-10-21 2010-04-22 Dierepharma, Inc. Composition and method for treating proteinuria
US7635707B1 (en) 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
US7816383B1 (en) * 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy
US8084475B2 (en) * 2009-12-04 2011-12-27 Intermune, Inc. Pirfenidone therapy and inducers of cytochrome P450
CA2824432C (en) * 2011-01-31 2021-10-19 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
AU2012225611B2 (en) 2011-03-08 2016-09-15 Auspex Pharmaceuticals, Inc. Substituted N-Aryl pyridinones
JP5872564B2 (ja) * 2011-09-14 2016-03-01 塩野義製薬株式会社 吸入用医薬組成物
WO2014012360A1 (en) 2012-07-18 2014-01-23 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
US12226407B2 (en) 2012-07-24 2025-02-18 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
CA2819967C (en) 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
AU2014366049B2 (en) * 2013-12-19 2018-04-05 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
WO2016122420A1 (en) 2015-01-26 2016-08-04 Ulkar Kimya Sanayii Ve Ticaret A. S. An improved method for the synthesis and purification of pirfenidone
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
TWI745396B (zh) 2016-07-12 2021-11-11 日商鹽野義製藥股份有限公司 吸入用醫藥組成物
CN109223723B (zh) * 2017-07-11 2021-08-27 南京华威医药科技集团有限公司 吡非尼酮片剂及其制备方法和用途
MX368750B (es) 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
MX2020005775A (es) * 2020-07-13 2022-01-14 Centro De Retina Medica Y Quirurgica S C Uso farmaceutico de pirfenidona para la reduccion de fibrosis cardiaca en pacientes con cardiomiopatia y/o esteatosis cardiaca y/o covid-19.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6816241A (enExample) * 1967-12-01 1969-06-03
US3721676A (en) * 1969-11-12 1973-03-20 Merck & Co Inc Certain 3-amino-2(1h)pyridones
US3644626A (en) * 1969-11-25 1972-02-22 Merck & Co Inc Novel pyridones in compositions and methods for treating inflammation pain and fever
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents
CA1049411A (en) * 1972-12-18 1979-02-27 Affiliated Medical Research N-substituted pyridone and general method for preparing pyridones
US4042699A (en) * 1972-12-18 1977-08-16 Affiliated Medical Research, Inc. Method for reducing serum glucose levels
US4052509A (en) * 1972-12-18 1977-10-04 Affiliated Medical Research, Inc. Method for reducing serum uric acid levels
ZA757570B (en) * 1974-12-09 1977-07-27 Affiliated Med Res A useful n-substituted pyridone
JPH02215719A (ja) * 1989-02-15 1990-08-28 Yamauchi Akitomo 線維化病変組織の修復並びに線維化病変の阻止剤

Also Published As

Publication number Publication date
EP1138329A2 (en) 2001-10-04
WO1990009176A1 (en) 1990-08-23
EP0383591A3 (en) 1992-01-15
CA2010017A1 (en) 1990-08-15
EP0383591A2 (en) 1990-08-22
EP0458861A4 (en) 1992-07-08
ES2220612T3 (es) 2004-12-16
EP0458861A1 (en) 1991-12-04
CA2010017C (en) 1995-09-05
DE69034143D1 (de) 2004-07-08
DE69033863T2 (de) 2002-06-13
JPH0552814B2 (enExample) 1993-08-06
EP1138329B8 (en) 2006-05-17
DE69034143T2 (de) 2005-06-30
AU4981290A (en) 1990-08-23
ES2163389T3 (es) 2002-02-01
EP0458861B1 (en) 1996-04-03
AU633541B2 (en) 1993-02-04
JPH02215719A (ja) 1990-08-28
EP1138329A3 (en) 2002-04-17
ATE136215T1 (de) 1996-04-15
DE69033863D1 (de) 2002-01-03
EP1138329B1 (en) 2004-06-02
EP0383591B1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
DK0458861T3 (da) Middel til reparation og forebyggelse af fibrotiske læsioner
NO960811D0 (no) Karbosykliske og heterosykliske kinolinkarboksylsyrer med kondenserte ringer som kan anvendes som immunresponsundertrykkende midler
DE69132439D1 (de) Inhibitoren retroviraler Proteasen
DK407483A (da) Antibakterielle naphthyridin-, quinolin- og benzoxazincarboxylsyrer, fremgangsmaader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling
NO162465C (no) Substituerte imidazolinyl-pyridiner og -kinoliner og anvendelse derav som herbicide midler.
FI944217A7 (fi) Substituoidut pipekoliinihappojohdannaiset HIV-proteaasin estäjinä
NO925041L (no) Nye 2-sakkarinylmetylaryl- og -aryloksyacetater som er nyttige som inhibitorer for proteolytiske enzymer samt preparater og anvendelse derav
FI935777A7 (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
MX9101861A (es) Novedosos 2-sacarinilmetil ari carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodo para usarlos
DE69307050D1 (de) Reihe von Elementen zum Gebrauch im belüfteten Fassadenbau
FI911269A7 (fi) Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
DK467885A (da) Middel til behandling og forebyggelse af diarre hos dyr og mennesker,og fremgangsmaade til fremstilling af et saadant middel
IT7851874A0 (it) Ti attrezzo e procedimento per giuntare assialmente due oggetti allunga
EE9600044A (et) Püranooni derivaadid kui proteaasi inhibiitorid ja viirusevastased toimeained
PT82166A (de) Heterocyclische disulfate und ihre anwendung als immunmodulatoren
AT388949B (de) Fahrbare gleisbearbeitungsmaschine fuer den weichen- und kreuzungsbereich
DK100087D0 (da) Transdermale 3-phenoxypyridin-praeparater
DK574178A (da) Indretning til rengoering af gulve trapper og lignende flader
ID817B (id) Alat penutup yang dapat dilepaskan
IT1184696B (it) Impalcatura semovente per lavori di restauro,imbiancatura e simili
ES292804Y (es) Estructuracion perfeccionada para frontis de armarios y muebles similares
FI960489A7 (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
MX9203685A (es) Nuevos derivados de mercaptoacetil-amida utiles como inhibidores de encefalinasa y ace.
BR6401935U (pt) Carrinho de chopp ambulantes
NO156674C (no) Regulerbart arbeidsbord og lignende for sengeliggende.